Watch the 25′ NEXT Debate from Dubrovnik on Agentic AI
In highly regulated environments like life sciences, scaling AI is about more than just automation. It’s about keeping control, earning trust, and making every recommendation explainable.
In this panel from NEXT Dubrovnik, industry leaders explore how Agentic AI delivers automation that stays transparent, contextual, and aligned with strategy—without removing human oversight.
Jeremy Flax, Vice President of Product Strategy at Aktana, shares how life sciences organizations are moving beyond static, rule-based systems by taking a practical, phased approach to Agentic AI.
The panel also features:
- Fabrizio Caranci, Executive Director, Global Digital Innovation at Angelini Pharma
- Megan Hughes (Reutin), Global Head of Data Science & Strategy at Grünenthal Group
- Paul Tunnah, Pharma Expert (Moderator)
What you’ll learn:
- How Agentic AI differs from conventional pharma AI
- Why explainability and traceability matter
- What real teams are learning about governance and trust
- What’s next—from optimization agents to contextual content
Whether you’re shaping your AI strategy or refining your next phase of deployment, this conversation offers a grounded, inside view into what’s working, and what’s next.
